.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Metastasis remains the primary cause of mortality in breast cancer patients. Recently, researchers have focused on collective migration, where specialized leader and follower cells coordinate movement. Consequently, understanding their metabolic signatures is vital. To achieve this, the study utilized single-cell lipid profiling to uncover unique signatures in Triple-Negative Breast Cancer (TNBC).
Specifically, the research team employed high-resolution mass spectrometry and microsampling on HCC1143 and HCC38 cell lines. By doing so, they tracked individual cells in real-time and identified over 120 metabolites. Moreover, this precise approach mapped lipidomic shifts during collective movement. Notably, the results highlighted significant functional heterogeneity within these aggressive cancer phenotypes.
Furthermore, the data revealed that metabolic profiles vary between leader and follower subpopulations. For instance, leader cells in the HCC38 line exhibited elevated fatty acids. Additionally, researchers detected significant alterations in phosphatidylethanolamine and diacylglycerol species. This suggests that specific lipids maintain the invasive capacity of leader cells.
In contrast, the HCC1143 line demonstrated distinct patterns involving phosphatidylcholine species. Particularly, the team confirmed the presence of PC(34:1) using fragment ions. As a result, the study proves that metabolic reprogramming is highly dynamic. Ultimately, these line-specific differences suggest that TNBC metabolism is not a uniform process.
Therefore, integrating dynamic imaging with single-cell analysis is essential for oncology research. In conclusion, understanding the metabolic engine of leader cells could lead to new therapeutic targets. Accordingly, these insights provide a promising roadmap for managing metastatic progression in the future.
Leader cells are specialized cells at the front of a migrating group that sense the environment and clear paths. Follower cells maintain the structure and provide force for collective movement.
It allows scientists to identify specific metabolic changes in individual cells. This reveals how different cell subpopulations contribute to tumor growth and spread, which bulk analysis might miss.
Depending on the cell line, leader cells showed increased levels of fatty acids, phosphatidylethanolamine, and diacylglycerol. These lipids likely support their unique role in driving invasion.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional diagnosis. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Huang X et al. Imaging-Guided Live Single-Cell Lipid Profiling of Leader and Follower Cellsduring Collective Migration of Triple-Negative Breast Cancer Cells. Adv Sci (Weinh). 2026 Jun 16. doi: 10.1002/advs.75862. PMID: 42301727.
Kim HY et al. Comparative metabolic and lipidomic profiling of human breast cancer cells with different metastatic potentials. Oncotarget. 2016 Aug 24;7(34):54173-54186. doi: 10.18632/oncotarget.11545.
Li J et al. Unveiling the impact of lipid metabolism on triple-negative breast cancer growth and treatment options. Front Oncol. 2024;14:1367018. doi: 10.3389/fonc.2024.1367018.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study using single-cell lipid profiling reveals that leader and follower cells in triple-negative breast cancer have distinct metabolic signatures. Researchers found line-specific changes in fatty acids and phospholipids, providing new insights into the mechanisms of collective cancer migration.
2 months ago
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
Last week
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
4 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
4 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
Last week
